NYSE ARCA | ETF
Under normal circumstances, the fund will invest at least 80% of its assets (plus any borrowings for investment purposes) in securities ofU. S. health care companies.
The fund adviser defines health care companies as companies included in the Global Industry Classification Standard health care sector.
The fund will typically invest in 50 " 100 health care companies.
The adviser generally seeks investments in companies that are developing new and effective medicines, as well as companies whose business models reduce costs or improve quality in health care systems.
Top 20 Holdings
Asset | Name | Sector | Industry | Weight |
---|---|---|---|---|
LLY | Eli Lilly and Company | Healthcare | Drug Manufacturers - General | 7.27% |
ISRG | Intuitive Surgical Inc | Healthcare | Medical Instruments & Supplies | 7.09% |
PCT | Purecycle Technologies Holdings Corp | Industrials | Pollution & Treatment Controls | 5.50% |
EYE | National Vision Holdings Inc | Consumer Cyclical | Specialty Retail | 5.39% |
DHR | Danaher Corporation | Healthcare | Diagnostics & Research | 4.90% |
ZTS | Zoetis Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 4.86% |
ABBV | AbbVie Inc | Healthcare | Drug Manufacturers - General | 4.84% |
NBIX | Neurocrine Biosciences Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 4.71% |
GILD | Gilead Sciences Inc | Healthcare | Drug Manufacturers - General | 4.69% |
ADMA | ADMA Biologics Inc | Healthcare | Biotechnology | 4.65% |
MDT | Medtronic PLC | Healthcare | Medical Devices | 4.65% |
ALGN | Align Technology Inc | Healthcare | Medical Devices | 4.64% |
ARQT | Arcutis Biotherapeutics Inc | Healthcare | Biotechnology | 4.23% |
NVO | Novo Nordisk A/S | Healthcare | Biotechnology | 3.70% |
PM | Philip Morris International Inc | Consumer Defensive | Tobacco | 3.62% |
SWAV | Shockwave Medical Inc | Healthcare | Medical Devices | 3.58% |
RHHBY | Roche Holding Ltd ADR | Healthcare | Drug Manufacturers - General | 2.94% |
CVS | CVS Health Corp | Healthcare | Healthcare Plans | 2.68% |
REGN | Regeneron Pharmaceuticals Inc | Healthcare | Biotechnology | 2.65% |
MYGN | Myriad Genetics Inc | Healthcare | Diagnostics & Research | 2.54% |